Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund(IDCW)
☆ Add to Watchlist
More Options
Business Overview
The Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund (IDCW) is designed for investors seeking exposure to the growing healthcare sector, both domestically and globally. This fund tracks the performance of the MSCI India Domestic & World Healthcare 45 Index, providing diversification and potential growth. It is ideal for those looking to invest in a sector that is resilient and essential, especially in times of uncertainty.
- Focuses on the healthcare sector
- Combines domestic and global exposure
- Ideal for long-term investors
- Offers diversification benefits
- Capitalizes on the growth of healthcare
Investment Thesis
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund offers a compelling investment opportunity backed by a credible promoter group. With the digital services sector poised for robust growth, this fund stands out for its attractive valuation compared to peers, making it a strategic choice for investors seeking exposure to the healthcare sector.
- Strong backing from Edelweiss, a reputable financial services group.
- Significant growth potential in digital healthcare services.
- Attractive valuation compared to similar funds in the market.
- Diversified exposure to both domestic and global healthcare sectors.
- Well-positioned to benefit from increasing healthcare spending.
Opportunity vs Risk
- Growing healthcare sector in India
- Rising demand for healthcare services
- Potential for long-term capital appreciation
- Diversification through global exposure
- Market volatility affecting returns
- Regulatory changes in healthcare
- Currency fluctuations impacting investments
- Dependence on sector performance
Peer Perspective
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund is currently trading at a slight premium compared to peers like Nippon India Healthcare Fund and SBI Healthcare Opportunities Fund; a rerating could occur with improved margin stability.
-
10BusinessHighHealthcare sector shows promise with increasing demand and innovation.
-
10GrowthHighConsistent revenue growth observed in healthcare sector, but fund performance varies.
-
10ProfitabilityHighROE and OCF are decent, but net profit margins can be volatile.
-
8ValuationHighValuation metrics are in line with peers, but some overvaluation concerns exist.
-
7BalanceHighBalance sheet is stable with manageable debt levels.
-
6GovernanceGoodPromoter holding is adequate, but transparency can improve.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with liquidity concerns.